Abeona Therapeutics (ABEO) Change in Acquisitions & Divestments (2018 - 2026)

Abeona Therapeutics' Change in Acquisitions & Divestments history runs 9 years deep, the most recent figure standing at $24.9 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 54.11% year-over-year to $24.9 million; the TTM figure through Mar 2026 stood at $123.0 million (down 19.19% YoY), while the FY2025 annual figure was $152.4 million, up 26.76% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $24.9 million, down from $33.6 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $54.3 million in Q1 2025, with the low at $8.7 million in Q1 2022.
• The 5-year median for Change in Acquisitions & Divestments is $22.3 million (2024), against an average of $23.7 million.
• The sharpest annual moves came in 2022 and 2024: Change in Acquisitions & Divestments plunged 65.32% in 2022, then soared 231.3% in 2024.
• Abeona Therapeutics' Change in Acquisitions & Divestments stood at $8.9 million in 2022, then soared by 67.46% to $15.0 million in 2023, then jumped by 100.22% to $30.0 million in 2024, then advanced by 12.08% to $33.6 million in 2025, then fell by 25.87% to $24.9 million in 2026.
• Business Quant data shows ABEO's Change in Acquisitions & Divestments at $24.9 million in Q1 2026, $33.6 million in Q4 2025, and $38.2 million in Q3 2025.